Weekly update Companies AI-cruiter Recruiting

Cellarity

Founded: 2017

Location: Cambridge, MA

Employee range: 50 - 200

Clinical stage: RD

Therapy area: Hematology conditions

Drug types: HEM, ONC

Lead product: Undisclosed

Product link: https://cellarity.com/cell-behavior

Funding: $121M C Oct 2022; $123M B Feb 2021

Investors: Flagship Pioneering, Kyowa Kirin, Hanwha Impact Partners, The Baupost Group, Banque Pictet

cellarity.com

linkedin.com

job board

Short description:

Drug Discovery, Unknown Modalities

Drug notes:

Undisclosed programs RD immuno-oncology, metabolic conditions

Long description:

Cellarity is developing medicines by understanding cell behaviors. Current drug discovery mediated by focusing on single molecular targets has a high clinical failure rate. Through the use of genomic technologies, data science and AI, Cellarity is instead unraveling the complexity of disease biology to target the underlying cellular dysfunction. Cellarity’s platform links biology and chemistry to provide critical insights into cellular dysfunction. The approach involves three key steps: identify cell dysfunction and build Cellarity Maps, evaluate interventions and then engineer new chemical entities. Cellarity currently has programs in hematology, immune-oncology and metabolism to generate new medicines.